Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Ryman Healthcare Ltd
NZX:RYM

Watchlist Manager
Ryman Healthcare Ltd Logo
Ryman Healthcare Ltd
NZX:RYM
Watchlist
Price: 1.985 NZD 2.32% Market Closed
Market Cap: NZ$2B
Write Note Create Alert Ask AI

Wall St Price Targets

RYM Price Targets Summary
Ryman Healthcare Ltd

Wall Street analysts forecast RYM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYM is 2.866 NZD with a low forecast of 2.586 NZD and a high forecast of 3.675 NZD.

RYM Lowest Forecast
Wall Street Target
NZ$2.586
30% Upside
RYM Average Forecast
Wall Street Target
NZ$2.866
44% Upside
RYM Highest Forecast
Wall Street Target
NZ$3.675
85% Upside
Lowest Forecast
Price Target
2.586 NZD
30% Upside
Average Forecast
Price Target
2.866 NZD
44% Upside
Highest Forecast
Price Target
3.675 NZD
85% Upside
Ryman Healthcare Ltd Competitors:
Price Targets

Revenue
Forecast

13% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
13% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

1% / Year
Past Growth
78% / Year
Estimated Growth
Estimates Accuracy
-78%
Average Miss
1% / Year
Past Growth
78% / Year
Estimated Growth
Estimates Accuracy
-78%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 78%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

What are analyst estimates?

Continue RYM Research

Summary
RYM intrinsic value, competitors valuation, and company profile.
DCF Valuation
RYM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RYM stock valuation using valuation multiples.
Wall St Estimates
RYM price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RYM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Ryman Healthcare Ltd listings:
OTC • USD
RYHTY
 OTC • USD
RHCGF
 F • EUR
RH7
 SWB • EUR
RH7
 F • EUR
RH70
 ASX • AUD
RYM
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RYM's stock price target?
Price Target
2.866 NZD

According to Wall Street analysts, the average 1-year price target for RYM is 2.866 NZD with a low forecast of 2.586 NZD and a high forecast of 3.675 NZD.

What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for Ryman Healthcare Ltd?
Projected CAGR
78%

Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 78%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.